Granules India stock crashes after USFDA concerns

Quick Summary:

The USFDA issued six observations to Granules India's Gagillapur facility in Hyderabad after an inspection between August 26 and September 6.

The company is committed to addressing these issues promptly and will submit its response within the stipulated time frame.

Following this news, Granules India's stock fell by over 16% on the BSE.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: TNN

Category: EconomyBusiness

Markets: IndiaPakistan

Topics: Pharmaceutical products Granules India Business news Gagillapur facility USFDA

Source Website Secure: Yes (HTTPS)

News Sentiment: Negative

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-09-13 @ 00:25:23 (6 hours ago)

News Timezone: GMT +5:00

News Source URL: timesofindia.indiatimes.com

Language: English

Article Length: 558 words

Reading Time: 4 minutes read

Sentences: 21 lines

Sentence Length: 27 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Times of India

News ID: 22476060

View Article Analysis

About Times of India

Main Topics: EconomyBusiness

Official Website: timesofindia.indiatimes.com

Update Frequency: 23 posts per day

Year Established: 1838

Headquarters: India

News Last Updated: 2 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Local / Regional

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #28

Publisher Details

Frequently Asked Questions